🔥Telegram İfşa

Introducing Bladder Health 3.0 My family history puts me at a higher risk of developing diabetes. Why do we wait for an arbitrary A1c level of 6.5 before formally diagnosing diabetes and offering therapeutics? There are no FDA approved treatments for “pre-diabetes” (A1c 5.7-6.4)

🔔Insights from Dr Marios Hadjipavlou Lecture on Men’s Health. 🎗️Prostate Cancer: - Most prevalent cancer in men, often asymptomatic in early stages - Curable if detected at an early stage - Over 95% of men diagnosed early with prostate cancer continue to have a normal life expectancy

Top Five #ProstateCancer Imaging Content of 2023: #5: 66 Percent of Men with Positive #MRI for Prostate Cancer Had Normal PSA Levels diagnosticimaging.com/view/study-66-… ACR RFS - We've Moved! Follow American College of Radiology. ACR YPS- We've Moved! Follow @RadiologyACR. @RadiologyACR ARRS RSNA Duke Radiology Penn Radiology @EmoryRadiology #radiology #RadRes

Λεπτομέρειες εγγραφής θα ακολουθήσουν προς το τέλος του μήνα. Σας περιμένουμε στη Λεμεσό.. More details to follow towards the end of the month. See you all there..

‼️ATTENTION‼️ Save this video in your smartphone! 📱 For the next time you have to explain to your patient the valve mechanism of the median lobe and the bladder damage.🥑 And why they can’t use alfa-bloq and 5-ARI in this situation…🙄 #BPH #MedianLobe #MiLEP #HoLEP #EEP

💫🌟🔬 Major updates from #EAU24 on prostate cancer (PCa) screening & diagnosis trials! 🚀🌟💫 OncoAlert Advanced Prostate Cancer Consensus Conference silke gillessen eaucongress.uroweb.org/game-changers-… 1️⃣ PRIME Study shows biparametric MRI equals multiparametric MRI in detecting significant PCa, suggesting a new

RIP Digital rectal examination? ☠️ Nice summary by Declan Murphy of the limitations of DRE in the primary care setting and for early detection for urologists (in settings where high quality MRI is available) #APCCC24

We are ✨incredibly proud✨ to be leading the #TRANSFORM prostate cancer screening trial in collaboration with our colleagues from UCL Queen Mary University of London The ICR The Royal Marsden NHS Foundation Trust Imperial College London supported by Prostate Cancer UK National Institute for Health and Care Research Movember UK

Results of a non-randomised, multi-centre, large study in >3k patients from ⁦Association Française d'Urologie - AFU⁩ comparing radical prostatectomy (RP) and HIFU (not focal) presented at #AUA24 The HIFU patients were older HIFU was non-inferior to RP HIFU licensed in France after this study

Quitting smoking after a cancer diagnosis significantly increases survival, regardless of cancer type The sooner you quit, the better: Those who quit within 3 months of diagnosis had a 25% lower risk of death, 6 months = 21% lower, and 9 months = 15% lower. 75th percentile

Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis by Akihiro Matsukawa et al buff.ly/3TRNPXK #UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

Enjoyed Focal vs Radical Tx debate Guy's Urology News for #FridayMorningMeeting Pro focal Deepika Reddy Pro radical @SamDavi97065439 Great to see the arguments put forward and then a (mostly) balanced discussion! #Equipoise/uncertainty #ProstateCancer

Compelling arguments by Hashim U. Ahmed at the Focal Therapy crossfire debate at #AUA2025 -Treatment side effects are reduced 5-10 fold -Iso-effective to radical therapy at 5-10 year -Focal therapy should be offered as a standard option for (eligible) intermediate patients

The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial NEJM #ASCO25 nejm.org/doi/full/10.10…

This is one of my all-time favorite BPH videos youtu.be/JT4IAihRHyE?si… by the genius urologist Bertrand Lukacs. Watching the ‘rolling ball’ median lobe was an epiphany for me…

📰👀Finger test ‘has no role in diagnosing prostate cancer today’ We, alongside Prostate Cancer UK, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer Via The Times and The Sunday Times: thetimes.com/uk/healthcare/…

Viewpoint: Prostate cancer screening is shifting toward a more beneficial and less harmful approach by using MRI-targeted strategies, which reduce unnecessary biopsies and overdiagnosis. ja.ma/45rVOSb Ivo Schoots

In this review, the authors assess the current state of #focal #therapy techniques for #prostate #cancer. 🔗to Full Article: mdpi.com/3347752 📜Latest Issue: mdpi.com/2563-6499/6/3?… SIU-Urology Peter Black Philippe spiess Lysanne Campeau, MD Professor Henry Woo Jeremy Teoh Amanda Chung

Can advanced imaging (mpMRI and PSMA PET) depict biology of PCa lesions? The answer is yes! A very nice collaboration between basic science and clinical researchers from Uniklinik Freiburg published in European Urology Link: kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2… 1/4

📢 MRI-led active surveillance for #ProstateCancer in 1150 men: 🧠 2 in 3 avoided biopsy at 5y 📉 91% EFS in MRI-invisible Gleason 3+3 ⚠️ Only 5% progressed to ≥Gleason 4+3 📚 Published in European Urology 🔗buff.ly/elyj2IG #UroTwitter #MRI #Urology #PCa